This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 April 2026, and includes updates on avian influenza, Salmonella Bovismorbificans, and

Most respiratory virus activity remains low overall across the EU/EEA. RSV: moderate activity but decreasing, with the seasonal peak already passed in most countries. Influenza:

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 April 2026, and includes updates on respiratory virus epidemiology in the

Most respiratory virus activity remains low overall across the EU/EEA. Influenza has returned to inter-seasonal levels. COVID 19 circulation is also very low. RSV activity

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 April 2026, and includes updates on avian influenza, dengue, and an

Most respiratory virus activity remains low overall across the EU/EEA. Influenza and COVID 19 circulation are low or continuing to decline. RSV activity remains elevated,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 March-3 April 2026 and includes updates on SARS-CoV-2 variant classification, Middle

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 March 2026 and includes updates on respiratory virus epidemiology in the

Most respiratory viruses are declining across the EU/EEA: Influenza circulation and hospitalisations are decreasing. SARS CoV 2 activity is low. RSV activity remains elevated, with

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14 -20 March 2026 and includes updates on respiratory virus epidemiology in

Respiratory virus trends across the EU/EEA continue to show early signs of decline. RSV circulation remains high, with children under five years the most affected.

Respiratory virus trends across the EU/EEA continue to show early signs of decline. RSV circulation remains high, with children under five most affected. Influenza circulation